Desai, K., Aiyappa, R., Prabhu, J. S., Nair, M. G., Lawrence, P. V., Korlimarla, A., . . . Sridhar, T. HR+HER2− breast cancers with growth factor receptor–mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells. SAGE Publishing.
Chicago Style (17th ed.) CitationDesai, Krisha, et al. HR+HER2− Breast Cancers with Growth Factor Receptor–mediated EMT Have a Poor Prognosis and Lapatinib Downregulates EMT in MCF-7 Cells. SAGE Publishing.
MLA (9th ed.) CitationDesai, Krisha, et al. HR+HER2− Breast Cancers with Growth Factor Receptor–mediated EMT Have a Poor Prognosis and Lapatinib Downregulates EMT in MCF-7 Cells. SAGE Publishing.
Warning: These citations may not always be 100% accurate.